Evidence map›Paper›PMID 30809084›Full record

ArticleWorld journal of gastroenterology2019

Aspiration therapy for acute embolic occlusion of the superior mesenteric artery.

Yi-Ren Liu, Zhu Tong, Cheng-Bei Hou, Shi-Jun Cui, Lian-Rui Guo, Yi-Xia Qi, Li-Xing Qi, Jian-Ming Guo, Yong-Quan Gu

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yi-Ren LiuDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Zhu TongDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Cheng-Bei HouCenter of Evidence-Based Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Shi-Jun CuiDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Lian-Rui GuoDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Yi-Xia QiDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Li-Xing QiDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Jian-Ming GuoDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Yong-Quan GuDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China. 15901598209@163.com.
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmbolic superior mesenteric artery (SMA) occlusion is associated with high mortality rates. Delayed treatment often leads to serious consequences, including intestinal necrosis, resection, and even patient death. Endovascular repair is being introduced, which can improve clinical symptoms and prognosis and decrease the incidence of exploratory laparotomy. Many reports have described successful endovascular revascularization of embolic SMA occlusion. However, most of those reports are case reports, and there are few reports on Chinese patients. In this paper, we describe the technical and clinical outcomes of aspiration therapy using a guiding catheter and long sheath technique which facilitates the endovascular repair procedure.

aimTo evaluate the complications, feasibility, effectiveness, and safety of endovascular treatment for the acute embolic occlusion of the SMA.

methodsThis retrospective study reviewed eight patients (six males and two females) from August 2013 to October 2018 at Xuanwu Hospital, Capital Medical University. The patients presented with acute embolic occlusion of the SMA on admission and were initially diagnosed by computed tomography angiography (CTA). The patients who underwent endovascular treatment with a guiding catheter had no obvious evidence of bowel infarct. No intestinal necrosis was identified by gastrointestinal surgeons through peritoneal puncture or CTA. The complications, feasibility, effectiveness, safety, and mortality were assessed.

resultsSix (75%) patients were male, and the mean patient age was 70.00 ± 8.43 years (range, 60-84 years). The acute embolic occlusion of the SMA was initially diagnosed by CTA. All patients had undertaken anticoagulation primarily, and percutaneous aspiration using a guiding catheter was then undertaken because the emboli had large amounts of thrombus residue. No death occurred among the patients. Complete patency of the suffering artery trunk was achieved in six patients, and defect filling was accomplished in two patients. The in-hospital mortality was 0%. The overall 12-mo survival rate was 100%. All patients survived, and two of the eight patients had complications (the clot broke off during aspiration).

conclusionAspiration therapy is feasible, safe, and beneficial for acute embolic SMA occlusion. Aspiration therapy has many benefits for reducing patients' death, resolving thrombi, and improving symptoms.

Indexed as

AgedAged, 80 and overAnticoagulantsChinaCombined Modality TherapyComputed Tomography AngiographyEndovascular ProceduresFeasibility StudiesFemaleHospital MortalityHumansMaleMesenteric Artery, SuperiorMesenteric Vascular OcclusionMiddle AgedPostoperative ComplicationsAnticoagulantsAcute embolic occlusionAspiration embolectomyEndovascular repairSuperior mesenteric arteryTranscatheter thrombolysis

Identifiers

PMID30809084
PMCPMC6385017
OpenAlexW2915957289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.